Natarajan Sethuraman
Technik-/Wissenschafts-/F&E-Leiter bei ENTRADA THERAPEUTICS, INC.
Vermögen: 3 Mio $ am 30.04.2024
Profil
Natarajan Sethuraman is currently the Chief Scientific Officer at Entrada Therapeutics, Inc. Previously, he worked at Merck & Co., Inc. as the Executive Director & Head-GlycoFi Site from 2012 to 2016.
He also worked as a Senior Scientist at Medical Enzymes AG.
Dr. Sethuraman received his graduate and doctorate degrees from the Indian Agricultural Research Institute and his undergraduate degree from Tamilnadu Agricultural University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ENTRADA THERAPEUTICS INC
0,62% | 05.03.2024 | 209 032 ( 0,62% ) | 3 Mio $ | 30.04.2024 |
Aktive Positionen von Natarajan Sethuraman
| Unternehmen | Position | Beginn |
|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2017 |
Ehemalige bekannte Positionen von Natarajan Sethuraman
| Unternehmen | Position | Ende |
|---|---|---|
| MERCK & CO., INC. | Direktor/Vorstandsmitglied | 01.07.2016 |
Medical Enzymes AG
 Medical Enzymes AG Medical/Nursing ServicesHealth Services Medical Enzymes AG is a privately held innovative biopharmaceutical company with a focus on therapeutically useful enzymes. The company has developed a new product family based on amino acid depleting enzymes. This unique approach is highly effective against cancer - the major target market of Medical Enzymes AG. Medical Enzymes business strategy focuses on the clinical development of therapeutic enzymes until clinical proof of concept and to commercialize those products through collaboration with selected pharmaceutical partners. | Corporate Officer/Principal | - |
Ausbildung von Natarajan Sethuraman
| Tamilnadu Agricultural University | Undergraduate Degree |
| Indian Agricultural Research Institute | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ENTRADA THERAPEUTICS, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Medical Enzymes AG
Medical Enzymes AG Medical/Nursing ServicesHealth Services Medical Enzymes AG is a privately held innovative biopharmaceutical company with a focus on therapeutically useful enzymes. The company has developed a new product family based on amino acid depleting enzymes. This unique approach is highly effective against cancer - the major target market of Medical Enzymes AG. Medical Enzymes business strategy focuses on the clinical development of therapeutic enzymes until clinical proof of concept and to commercialize those products through collaboration with selected pharmaceutical partners. | Health Services |
